Plasma Renin and Cardiovascular Risk: What Is the Evidence for an Association

THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT) BIOMARKER PROGRAMME

(2013) C. Chan et al.   JOURNAL OF HYPERTENSION

Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

(2012) P. S. Sever et al.   EUROPEAN HEART JOURNAL

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

(2012) John J.V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

Plasma renin activity predicts renal impairment

(2012) Thomas Unger   Nature Reviews Nephrology

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

(2012) Hans-Henrik Parving et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prognostic Value of Plasma Renin Activity in Heart Failure

(2011) Giuseppe Vergaro et al.   AMERICAN JOURNAL OF CARDIOLOGY

Enduring Direct Association of Baseline Plasma Renin Activity With All-Cause and Cardiovascular Mortality in Hypertensive Patients

(2011) M. C. Gonzalez et al.   AMERICAN JOURNAL OF HYPERTENSION

The Plasma Renin Test Reveals the Contribution of Body Sodium-Volume Content (V) and Renin-Angiotensin (R) Vasoconstriction to Long-Term Blood Pressure

(2011) J. H. Laragh et al.   AMERICAN JOURNAL OF HYPERTENSION

Plasma renin activity predicts cardiovascular mortality in the Heart Outcomes Prevention Evaluation (HOPE) study

(2011) Subodh Verma et al.   EUROPEAN HEART JOURNAL

Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure

(2011) A. Tomaschitz et al.   EUROPEAN HEART JOURNAL

Association of (pro)renin receptor gene polymorphisms with lacunar infarction and left ventricular hypertrophy in Japanese women: the Ohasama study

(2011) Takuo Hirose et al.   HYPERTENSION RESEARCH

Higher plasma renin activity is a risk factor for total mortality in older Japanese individuals: the Takahata study

(2011) Makoto Daimon et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The role of beta-blockers in the treatment of chronic heart failure

(2011) Christer Kubon et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Relation of Elevated Plasma Renin Activity at Baseline to Cardiac Events in Patients With Angiographically Proven Coronary Artery Disease

(2010) Joseph B. Muhlestein et al.   AMERICAN JOURNAL OF CARDIOLOGY

Pressor Responses to Antihypertensive Drug Types

(2010) M. H. Alderman et al.   AMERICAN JOURNAL OF HYPERTENSION

Plasma Renin Activity Predicts Blood Pressure Responses to  -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for Hypertension

(2010) S. T. Turner et al.   AMERICAN JOURNAL OF HYPERTENSION

Prediction of Long-Term Survival in Chronic Heart Failure by Multiple Biomarker Assessment: A 15-Year Prospective Follow-Up Study

(2010) Massimo Volpe et al.   CLINICAL CARDIOLOGY

Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patients

(2010) Akiko Aoki et al.   HEART AND VESSELS

Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

(2010) Serge Masson et al.   JOURNAL OF CARDIAC FAILURE

Review: Plasma renin and the incidence of cardiovascular disease

(2010) Tom Meade   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Association of (Pro)renin Receptor Gene Polymorphism With Blood Pressure in Japanese Men: The Ohasama Study

(2009) T. Hirose et al.   AMERICAN JOURNAL OF HYPERTENSION

Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial

(2009) B. M. Egan et al.   AMERICAN JOURNAL OF HYPERTENSION

Signal transduction of the (pro)renin receptor as a novel therapeutic target for preventing end-organ damage

(2009) Heiko Funke-Kaiser et al.   HYPERTENSION RESEARCH

Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

(2008) Steven G. Chrysant et al.   CURRENT MEDICAL RESEARCH AND OPINION

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Predictors of Blood Pressure Response to the Angiotensin Receptor Blocker Candesartan in Essential Hypertension

(2007) V. J. Canzanello et al.   AMERICAN JOURNAL OF HYPERTENSION